Pflücke F
Z Gesamte Inn Med. 1981 Feb 15;36(4):122-4.
By sequence analysis was proved that metoclopramide (cerucal, 3 x 10 mg p.o.) in comparison to placebo removes or relieves typical complaints of the reflux disease. Still one week after the end off the treatment with metoclopramide the gastrooesophageal reflux under fasting conditions was significantly decreased compared with the beginning of the treatment, whereas the reflux stimulated under pentagastrin did not show a remaining influence.
通过序列分析证明,与安慰剂相比,甲氧氯普胺(胃复安,口服3×10毫克)可消除或缓解反流性疾病的典型症状。在停用甲氧氯普胺治疗一周后,空腹条件下的胃食管反流与治疗开始时相比显著降低,而在五肽胃泌素刺激下的反流未显示出持续影响。